Rapport Therapeutics Inc. – Indentures

NASDAQ: RAPP
Share price (8/10/26): $46.98
Market cap (8/10/26): $2.254 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from S-3ASR 41 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-3ASR 40 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities

from S-3 41 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-3 40 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities

from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended

from S-1 32 pages Rapport Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement August 7, 2023

from S-1 2 pages Indenture or similar

from DRS 32 pages Rapport Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement August 7, 2023